1 Study Coverage 1.1 Irbesartan Product Introduction 1.2 Market by Type 1.2.1 Global Irbesartan Market Size Growth Rate by Type 1.2.2 Combination Drugs 1.2.3 Prescribed Drugs 1.3 Market by Application 1.3.1 Global Irbesartan Market Size Growth Rate by Application 1.3.2 Hyperlipidemia 1.3.3 High Blood Pressure 1.3.4 Heart Failure 1.3.5 Kidney Disease 1.3.6 Fibrous Fibrillation 1.3.7 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Irbesartan Market Size, Estimates and Forecasts 2.1.1 Global Irbesartan Revenue 2016-2027 2.1.2 Global Irbesartan Sales 2016-2027 2.2 Global Irbesartan, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Irbesartan Historical Market Size by Region (2016-2021) 2.3.1 Global Irbesartan Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Irbesartan Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Irbesartan Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Irbesartan Sales Forecast by Region (2022-2027) 2.4.2 Global Irbesartan Revenue Forecast by Region (2022-2027) 3 Global Irbesartan Competitor Landscape by Players 3.1 Global Top Irbesartan Manufacturers by Sales 3.1.1 Global Irbesartan Sales by Manufacturer (2016-2021) 3.1.2 Global Irbesartan Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Irbesartan Manufacturers by Revenue 3.2.1 Key Irbesartan Manufacturers Covered: Ranking by Revenue 3.2.2 Global Irbesartan Revenue by Manufacturers (2016-2021) 3.2.3 Global Irbesartan Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Irbesartan Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Irbesartan Revenue in 2020 3.2.6 Global Irbesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Irbesartan Price by Manufacturers 3.4 Global Irbesartan Manufacturing Base Distribution, Product Types 3.4.1 Irbesartan Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Irbesartan Product Type 3.4.3 Date of International Manufacturers Enter into Irbesartan Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Irbesartan Market Size by Type (2016-2021) 4.1.1 Global Irbesartan Sales by Type (2016-2021) 4.1.2 Global Irbesartan Revenue by Type (2016-2021) 4.1.3 Irbesartan Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Irbesartan Market Size Forecast by Type (2022-2027) 4.2.1 Global Irbesartan Sales Forecast by Type (2022-2027) 4.2.2 Global Irbesartan Revenue Forecast by Type (2022-2027) 4.2.3 Irbesartan Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Irbesartan Market Size by Application (2016-2021) 5.1.1 Global Irbesartan Sales by Application (2016-2021) 5.1.2 Global Irbesartan Revenue by Application (2016-2021) 5.1.3 Irbesartan Price by Application (2016-2021) 5.2 Irbesartan Market Size Forecast by Application (2022-2027) 5.2.1 Global Irbesartan Sales Forecast by Application (2022-2027) 5.2.2 Global Irbesartan Revenue Forecast by Application (2022-2027) 5.2.3 Global Irbesartan Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Irbesartan Market Size YoY Growth 2016-2027 6.1.1 Japan Irbesartan Sales YoY Growth 2016-2027 6.1.2 Japan Irbesartan Revenue YoY Growth 2016-2027 6.1.3 Japan Irbesartan Market Share in Global Market 2016-2027 6.2 Japan Irbesartan Market Size by Players (International and Local Players) 6.2.1 Japan Top Irbesartan Players by Sales (2016-2021) 6.2.2 Japan Top Irbesartan Players by Revenue (2016-2021) 6.3 Japan Irbesartan Historic Market Review by Type (2016-2021) 6.3.1 Japan Irbesartan Sales Market Share by Type (2016-2021) 6.3.2 Japan Irbesartan Revenue Market Share by Type (2016-2021) 6.3.3 Japan Irbesartan Price by Type (2016-2021) 6.4 Japan Irbesartan Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Irbesartan Sales Forecast by Type (2022-2027) 6.4.2 Japan Irbesartan Revenue Forecast by Type (2022-2027) 6.4.3 Japan Irbesartan Price Forecast by Type (2022-2027) 6.5 Japan Irbesartan Historic Market Review by Application (2016-2021) 6.5.1 Japan Irbesartan Sales Market Share by Application (2016-2021) 6.5.2 Japan Irbesartan Revenue Market Share by Application (2016-2021) 6.5.3 Japan Irbesartan Price by Application (2016-2021) 6.6 Japan Irbesartan Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Irbesartan Sales Forecast by Application (2022-2027) 6.6.2 Japan Irbesartan Revenue Forecast by Application (2022-2027) 6.6.3 Japan Irbesartan Price Forecast by Application (2022-2027) 7 North America 7.1 North America Irbesartan Market Size YoY Growth 2016-2027 7.2 North America Irbesartan Market Facts & Figures by Country 7.2.1 North America Irbesartan Sales by Country (2016-2021) 7.2.2 North America Irbesartan Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Irbesartan Market Size YoY Growth 2016-2027 8.2 Asia Pacific Irbesartan Market Facts & Figures by Region 8.2.1 Asia Pacific Irbesartan Sales by Region (2016-2021) 8.2.2 Asia Pacific Irbesartan Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Irbesartan Market Size YoY Growth 2016-2027 9.2 Europe Irbesartan Market Facts & Figures by Country 9.2.1 Europe Irbesartan Sales by Country (2016-2021) 9.2.2 Europe Irbesartan Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Irbesartan Market Size YoY Growth 2016-2027 10.2 Latin America Irbesartan Market Facts & Figures by Country 10.2.1 Latin America Irbesartan Sales by Country (2016-2021) 10.2.2 Latin America Irbesartan Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Irbesartan Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Irbesartan Market Facts & Figures by Country 11.2.1 Middle East and Africa Irbesartan Sales by Country (2016-2021) 11.2.2 Middle East and Africa Irbesartan Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Teva 12.1.1 Teva Corporation Information 12.1.2 Teva Description and Business Overview 12.1.3 Teva Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Teva Irbesartan Products Offered 12.1.5 Teva Recent Development 12.2 Sanofi 12.2.1 Sanofi Corporation Information 12.2.2 Sanofi Description and Business Overview 12.2.3 Sanofi Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Sanofi Irbesartan Products Offered 12.2.5 Sanofi Recent Development 12.3 BMS 12.3.1 BMS Corporation Information 12.3.2 BMS Description and Business Overview 12.3.3 BMS Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.3.4 BMS Irbesartan Products Offered 12.3.5 BMS Recent Development 12.4 Sumitomo Dainippon Pharma 12.4.1 Sumitomo Dainippon Pharma Corporation Information 12.4.2 Sumitomo Dainippon Pharma Description and Business Overview 12.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Sumitomo Dainippon Pharma Irbesartan Products Offered 12.4.5 Sumitomo Dainippon Pharma Recent Development 12.5 Novartis 12.5.1 Novartis Corporation Information 12.5.2 Novartis Description and Business Overview 12.5.3 Novartis Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Novartis Irbesartan Products Offered 12.5.5 Novartis Recent Development 12.6 Shionogi 12.6.1 Shionogi Corporation Information 12.6.2 Shionogi Description and Business Overview 12.6.3 Shionogi Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Shionogi Irbesartan Products Offered 12.6.5 Shionogi Recent Development 12.7 Hanall 12.7.1 Hanall Corporation Information 12.7.2 Hanall Description and Business Overview 12.7.3 Hanall Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Hanall Irbesartan Products Offered 12.7.5 Hanall Recent Development 12.8 Taj Pharmaceuticals 12.8.1 Taj Pharmaceuticals Corporation Information 12.8.2 Taj Pharmaceuticals Description and Business Overview 12.8.3 Taj Pharmaceuticals Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Taj Pharmaceuticals Irbesartan Products Offered 12.8.5 Taj Pharmaceuticals Recent Development 12.9 Apotex 12.9.1 Apotex Corporation Information 12.9.2 Apotex Description and Business Overview 12.9.3 Apotex Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Apotex Irbesartan Products Offered 12.9.5 Apotex Recent Development 12.10 Jiangsu Hengrui Medicine 12.10.1 Jiangsu Hengrui Medicine Corporation Information 12.10.2 Jiangsu Hengrui Medicine Description and Business Overview 12.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Jiangsu Hengrui Medicine Irbesartan Products Offered 12.10.5 Jiangsu Hengrui Medicine Recent Development 12.11 Teva 12.11.1 Teva Corporation Information 12.11.2 Teva Description and Business Overview 12.11.3 Teva Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Teva Irbesartan Products Offered 12.11.5 Teva Recent Development 12.12 Angita Pharma 12.12.1 Angita Pharma Corporation Information 12.12.2 Angita Pharma Description and Business Overview 12.12.3 Angita Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Angita Pharma Products Offered 12.12.5 Angita Pharma Recent Development 12.13 Auro Pharma 12.13.1 Auro Pharma Corporation Information 12.13.2 Auro Pharma Description and Business Overview 12.13.3 Auro Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Auro Pharma Products Offered 12.13.5 Auro Pharma Recent Development 12.14 Avanstra 12.14.1 Avanstra Corporation Information 12.14.2 Avanstra Description and Business Overview 12.14.3 Avanstra Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Avanstra Products Offered 12.14.5 Avanstra Recent Development 12.15 Zhuhai Rundu Pharma 12.15.1 Zhuhai Rundu Pharma Corporation Information 12.15.2 Zhuhai Rundu Pharma Description and Business Overview 12.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Zhuhai Rundu Pharma Products Offered 12.15.5 Zhuhai Rundu Pharma Recent Development 12.16 Xiansheng Pharmaceutical 12.16.1 Xiansheng Pharmaceutical Corporation Information 12.16.2 Xiansheng Pharmaceutical Description and Business Overview 12.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Xiansheng Pharmaceutical Products Offered 12.16.5 Xiansheng Pharmaceutical Recent Development 12.17 CTTQ 12.17.1 CTTQ Corporation Information 12.17.2 CTTQ Description and Business Overview 12.17.3 CTTQ Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.17.4 CTTQ Products Offered 12.17.5 CTTQ Recent Development 12.18 Tianjin Huairen Pharmaceutical 12.18.1 Tianjin Huairen Pharmaceutical Corporation Information 12.18.2 Tianjin Huairen Pharmaceutical Description and Business Overview 12.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Tianjin Huairen Pharmaceutical Products Offered 12.18.5 Tianjin Huairen Pharmaceutical Recent Development 12.19 Jiangsu Wangao Pharmaceutical 12.19.1 Jiangsu Wangao Pharmaceutical Corporation Information 12.19.2 Jiangsu Wangao Pharmaceutical Description and Business Overview 12.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Jiangsu Wangao Pharmaceutical Products Offered 12.19.5 Jiangsu Wangao Pharmaceutical Recent Development 12.20 Zhejiang Huahai Pharmaceutical 12.20.1 Zhejiang Huahai Pharmaceutical Corporation Information 12.20.2 Zhejiang Huahai Pharmaceutical Description and Business Overview 12.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Zhejiang Huahai Pharmaceutical Products Offered 12.20.5 Zhejiang Huahai Pharmaceutical Recent Development 12.21 Zhejiang Ainuo Pharmaceutical 12.21.1 Zhejiang Ainuo Pharmaceutical Corporation Information 12.21.2 Zhejiang Ainuo Pharmaceutical Description and Business Overview 12.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Zhejiang Ainuo Pharmaceutical Products Offered 12.21.5 Zhejiang Ainuo Pharmaceutical Recent Development 12.22 Yuanhe Pharmaceutical 12.22.1 Yuanhe Pharmaceutical Corporation Information 12.22.2 Yuanhe Pharmaceutical Description and Business Overview 12.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Yuanhe Pharmaceutical Products Offered 12.22.5 Yuanhe Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Irbesartan Industry Trends 13.2 Irbesartan Market Drivers 13.3 Irbesartan Market Challenges 13.4 Irbesartan Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Irbesartan Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Irbesartan Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Combination Drugs Table 3. Major Manufacturers of Prescribed Drugs Table 4. Global Irbesartan Market Size Growth Rate by Application (2021-2027) & (KG) Table 5. Global Irbesartan Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Irbesartan Sales by Regions (2016-2021) & (KG) Table 7. Global Irbesartan Sales Market Share by Regions (2016-2021) Table 8. Global Irbesartan Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Irbesartan Sales Forecast by Region (2022-2027) & (KG) Table 10. Global Irbesartan Sales Market Share Forecast by Region (2022-2027) Table 11. Global Irbesartan Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Irbesartan Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Irbesartan Sales by Manufacturers (2016-2021) (KG) Table 14. Global Irbesartan Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Irbesartan Manufacturers by Revenue (US$ Million) in 2020 Table 16. Irbesartan Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Irbesartan Revenue Share by Manufacturers (2016-2021) Table 18. Global Irbesartan Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Irbesartan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irbesartan as of 2020) Table 20. Key Manufacturers Irbesartan Price (2016-2021) (US$/G) Table 21. Irbesartan Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Irbesartan Product Type Table 23. Date of International Manufacturers Enter into Irbesartan Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Irbesartan Sales by Type (2016-2021) (KG) Table 26. Global Irbesartan Sales Share by Type (2016-2021) Table 27. Global Irbesartan Revenue by Type (2016-2021) (US$ Million) Table 28. Global Irbesartan Revenue Share by Type (2016-2021) Table 29. Irbesartan Average Selling Price (ASP) by Type (2016-2021) & (US$/G) Table 30. Global Irbesartan Sales Forecast by Type (2022-2027) & (KG) Table 31. Global Irbesartan Sales Market Share Forecast by Type (2022-2027) Table 32. Global Irbesartan Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Irbesartan Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Irbesartan Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/G) Table 35. Global Irbesartan Sales by Application (2016-2021) (KG) Table 36. Global Irbesartan Sales Share by Application (2016-2021) Table 37. Global Irbesartan Revenue by Application (2016-2021) (US$ Million) Table 38. Global Irbesartan Revenue Share by Application (2016-2021) Table 39. Irbesartan Average Selling Price (ASP) by Application (2016-2021) & (US$/G) Table 40. Global Irbesartan Sales Forecast by Application (2022-2027) & (KG) Table 41. Global Irbesartan Sales Market Share Forecast by Application (2022-2027) Table 42. Global Irbesartan Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Irbesartan Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Irbesartan Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/G) Table 45. Japan Irbesartan Sales (KG) of Key Companies (2016-2021) Table 46. Japan Irbesartan Sales Share by Company (2016-2021) Table 47. Japan Irbesartan Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Irbesartan Revenue Share by Company (2016-2021) Table 49. Japan Irbesartan Sales (KG) by Type (2016-2021) Table 50. Japan Irbesartan Sales Share by Type (2016-2021) Table 51. Japan Irbesartan Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Irbesartan Price (US$/G) by Type (2016-2021) Table 53. Japan Irbesartan Sales (KG) by Type (2022-2027) Table 54. Japan Irbesartan Sales Share by Type (2022-2027) Table 55. Japan Irbesartan Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Irbesartan Revenue Share by Type (2022-2027) Table 57. Japan Irbesartan Price (US$/G) by Type (2022-2027) Table 58. Japan Irbesartan Sales (KG) by Application (2016-2021) Table 59. Japan Irbesartan Sales Share by Application (2016-2021) Table 60. Japan Irbesartan Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Irbesartan Price (US$/G) by Application (2016-2021) Table 62. Japan Irbesartan Sales (KG) by Application (2022-2027) Table 63. Japan Irbesartan Sales Share by Application (2022-2027) Table 64. Japan Irbesartan Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Irbesartan Revenue Share by Application (2022-2027) Table 66. Japan Irbesartan Price (US$/G) by Application (2022-2027) Table 67. North America Irbesartan Sales by Country (2016-2021) & (KG) Table 68. North America Irbesartan Sales Market Share by Country (2016-2021) Table 69. North America Irbesartan Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Irbesartan Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Irbesartan Sales by Region (2016-2021) & (KG) Table 72. Asia Pacific Irbesartan Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Irbesartan Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Irbesartan Revenue Market Share by Region (2016-2021) Table 75. Europe Irbesartan Sales by Country (2016-2021) & (KG) Table 76. Europe Irbesartan Sales Market Share by Country (2016-2021) Table 77. Europe Irbesartan Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Irbesartan Revenue Market Share by Country (2016-2021) Table 79. Latin America Irbesartan Sales by Country (2016-2021) & (KG) Table 80. Latin America Irbesartan Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Irbesartan Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Irbesartan Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Irbesartan Sales by Country (2016-2021) & (KG) Table 84. Middle East and Africa Irbesartan Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Irbesartan Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Irbesartan Revenue Market Share by Country (2016-2021) Table 87. Teva Corporation Information Table 88. Teva Description and Business Overview Table 89. Teva Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 90. Teva Irbesartan Product Table 91. Teva Recent Development Table 92. Sanofi Corporation Information Table 93. Sanofi Description and Business Overview Table 94. Sanofi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 95. Sanofi Product Table 96. Sanofi Recent Development Table 97. BMS Corporation Information Table 98. BMS Description and Business Overview Table 99. BMS Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 100. BMS Product Table 101. BMS Recent Development Table 102. Sumitomo Dainippon Pharma Corporation Information Table 103. Sumitomo Dainippon Pharma Description and Business Overview Table 104. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 105. Sumitomo Dainippon Pharma Product Table 106. Sumitomo Dainippon Pharma Recent Development Table 107. Novartis Corporation Information Table 108. Novartis Description and Business Overview Table 109. Novartis Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 110. Novartis Product Table 111. Novartis Recent Development Table 112. Shionogi Corporation Information Table 113. Shionogi Description and Business Overview Table 114. Shionogi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 115. Shionogi Product Table 116. Shionogi Recent Development Table 117. Hanall Corporation Information Table 118. Hanall Description and Business Overview Table 119. Hanall Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 120. Hanall Product Table 121. Hanall Recent Development Table 122. Taj Pharmaceuticals Corporation Information Table 123. Taj Pharmaceuticals Description and Business Overview Table 124. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 125. Taj Pharmaceuticals Product Table 126. Taj Pharmaceuticals Recent Development Table 127. Apotex Corporation Information Table 128. Apotex Description and Business Overview Table 129. Apotex Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 130. Apotex Product Table 131. Apotex Recent Development Table 132. Jiangsu Hengrui Medicine Corporation Information Table 133. Jiangsu Hengrui Medicine Description and Business Overview Table 134. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 135. Jiangsu Hengrui Medicine Product Table 136. Jiangsu Hengrui Medicine Recent Development Table 137. Verdant Life Sciences Corporation Information Table 138. Verdant Life Sciences Description and Business Overview Table 139. Verdant Life Sciences Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 140. Verdant Life Sciences Product Table 141. Verdant Life Sciences Recent Development Table 142. Angita Pharma Corporation Information Table 143. Angita Pharma Description and Business Overview Table 144. Angita Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 145. Angita Pharma Product Table 146. Angita Pharma Recent Development Table 147. Auro Pharma Corporation Information Table 148. Auro Pharma Description and Business Overview Table 149. Auro Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 150. Auro Pharma Product Table 151. Auro Pharma Recent Development Table 152. Avanstra Corporation Information Table 153. Avanstra Description and Business Overview Table 154. Avanstra Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 155. Avanstra Product Table 156. Avanstra Recent Development Table 157. Zhuhai Rundu Pharma Corporation Information Table 158. Zhuhai Rundu Pharma Description and Business Overview Table 159. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 160. Zhuhai Rundu Pharma Product Table 161. Zhuhai Rundu Pharma Recent Development Table 162. Xiansheng Pharmaceutical Corporation Information Table 163. Xiansheng Pharmaceutical Description and Business Overview Table 164. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 165. Xiansheng Pharmaceutical Product Table 166. Xiansheng Pharmaceutical Recent Development Table 167. CTTQ Corporation Information Table 168. CTTQ Description and Business Overview Table 169. CTTQ Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 170. CTTQ Product Table 171. CTTQ Recent Development Table 172. Tianjin Huairen Pharmaceutical Corporation Information Table 173. Tianjin Huairen Pharmaceutical Description and Business Overview Table 174. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 175. Tianjin Huairen Pharmaceutical Product Table 176. Tianjin Huairen Pharmaceutical Recent Development Table 177. Jiangsu Wangao Pharmaceutical Corporation Information Table 178. Jiangsu Wangao Pharmaceutical Description and Business Overview Table 179. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 180. Jiangsu Wangao Pharmaceutical Product Table 181. Jiangsu Wangao Pharmaceutical Recent Development Table 182. Zhejiang Huahai Pharmaceutical Corporation Information Table 183. Zhejiang Huahai Pharmaceutical Description and Business Overview Table 184. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 185. Zhejiang Huahai Pharmaceutical Product Table 186. Zhejiang Huahai Pharmaceutical Recent Development Table 187. Zhejiang Ainuo Pharmaceutical Corporation Information Table 188. Zhejiang Ainuo Pharmaceutical Description and Business Overview Table 189. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 190. Zhejiang Ainuo Pharmaceutical Product Table 191. Zhejiang Ainuo Pharmaceutical Recent Development Table 192. Yuanhe Pharmaceutical Corporation Information Table 193. Yuanhe Pharmaceutical Description and Business Overview Table 194. Yuanhe Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 195. Yuanhe Pharmaceutical Product Table 196. Yuanhe Pharmaceutical Recent Development Table 197. Irbesartan Market Trends Table 198. Irbesartan Market Drivers Table 199. Irbesartan Market Challenges Table 200. Irbesartan Market Restraints Table 201. Irbesartan Customers List Table 202. Irbesartan Distributors List Table 203. Research Programs/Design for This Report Table 204. Key Data Information from Secondary Sources Table 205. Key Data Information from Primary Sources List of Figures Figure 1. Irbesartan Product Picture Figure 2. Global Irbesartan Sales Market Share by Type in 2020 & 2027 Figure 3. Combination Drugs Product Picture Figure 4. Prescribed Drugs Product Picture Figure 5. Global Irbesartan Sales Market Share by Application in 2020 & 2027 Figure 6. Hyperlipidemia Figure 7. High Blood Pressure Figure 8. Heart Failure Figure 9. Kidney Disease Figure 10. Fibrous Fibrillation Figure 11. Other Figure 12. Irbesartan Report Years Considered Figure 13. Global Irbesartan Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Irbesartan Market Size 2016-2027 (US$ Million) Figure 15. Global Irbesartan Sales 2016-2027 (KG) Figure 16. Global Irbesartan Market Size Market Share by Region: 2021 Versus 2027 Figure 17. Global Irbesartan Sales Market Share by Region (2016-2021) Figure 18. Global Irbesartan Sales Market Share by Region in 2020 Figure 19. Global Irbesartan Revenue Market Share by Region (2016-2021) Figure 20. Global Irbesartan Revenue Market Share by Region in 2020 Figure 21. Global Irbesartan Sales Share by Manufacturer in 2020 Figure 22. The Top 10 and 5 Players Market Share by Irbesartan Revenue in 2020 Figure 23. Irbesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 24. Global Irbesartan Sales Market Share by Type (2016-2021) Figure 25. Global Irbesartan Sales Market Share by Type in 2020 Figure 26. Global Irbesartan Revenue Market Share by Type (2016-2021) Figure 27. Global Irbesartan Revenue Market Share by Type in 2020 Figure 28. Global Irbesartan Sales Market Share by Application (2016-2021) Figure 29. Global Irbesartan Sales Market Share by Application in 2020 Figure 30. Global Irbesartan Revenue Market Share by Application (2016-2021) Figure 31. Global Irbesartan Revenue Market Share by Application in 2020 Figure 32. Japan Irbesartan Sales Growth Rate 2016-2027 (KG) Figure 33. Japan Irbesartan Revenue Growth Rate 2016-2027 (US$ Million) Figure 34. Japan Irbesartan Market Share in Global Market 2016-2027 Figure 35. Japan 5 and 10 Largest Irbesartan Players Market Share by Revenue in Irbesartan in 2020 Figure 36. Japan Irbesartan Revenue Share by Type (2016-2021) Figure 37. Japan Irbesartan Revenue Growth Rate by Type in 2016 & 2020 Figure 38. Japan Irbesartan Revenue Share by Application (2016-2021) Figure 39. Japan Irbesartan Revenue Growth Rate by Application in 2016 & 2020 Figure 40. North America Irbesartan Sales Growth Rate 2016-2021 (KG) Figure 41. North America Irbesartan Revenue Growth Rate 2016-2021 (US$ Million) Figure 42. North America Irbesartan Sales Market Share by Country in 2020 Figure 43. North America Irbesartan Revenue Market Share by Country in 2020 Figure 44. U.S. Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 45. U.S. Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Canada Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 47. Canada Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Europe Irbesartan Sales Growth Rate 2016-2021 (KG) Figure 49. Europe Irbesartan Revenue Growth Rate 2016-2021 (US$ Million) Figure 50. Europe Irbesartan Sales Market Share by Country in 2020 Figure 51. Europe Irbesartan Revenue Market Share by Country in 2020 Figure 52. Germany Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 53. Germany Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. France Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 55. France Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. U.K. Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 57. U.K. Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Italy Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 59. Italy Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Russia Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 61. Russia Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 62. Asia Pacific Irbesartan Sales Growth Rate 2016-2021 (KG) Figure 63. Asia Pacific Irbesartan Revenue Growth Rate 2016-2021 (US$ Million) Figure 64. Asia Pacific Irbesartan Sales Market Share by Region in 2020 Figure 65. Asia Pacific Irbesartan Revenue Market Share by Region in 2020 Figure 66. China Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 67. China Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. Japan Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 69. Japan Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. South Korea Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 71. South Korea Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. India Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 73. India Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Australia Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 75. Australia Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Taiwan Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 77. Taiwan Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Indonesia Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 79. Indonesia Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Thailand Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 81. Thailand Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Malaysia Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 83. Malaysia Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Philippines Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 85. Philippines Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Vietnam Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 87. Vietnam Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 88. Latin America Irbesartan Sales Growth Rate 2016-2021 (KG) Figure 89. Latin America Irbesartan Revenue Growth Rate 2016-2021 (US$ Million) Figure 90. Latin America Irbesartan Sales Market Share by Country in 2020 Figure 91. Latin America Irbesartan Revenue Market Share by Country in 2020 Figure 92. Mexico Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 93. Mexico Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Brazil Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 95. Brazil Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Argentina Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 97. Argentina Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 98. Middle East and Africa Irbesartan Sales Growth Rate 2016-2021 (KG) Figure 99. Middle East and Africa Irbesartan Revenue Growth Rate 2016-2021 (US$ Million) Figure 100. Middle East and Africa Irbesartan Sales Market Share by Country in 2020 Figure 101. Middle East and Africa Irbesartan Revenue Market Share by Country in 2020 Figure 102. Turkey Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 103. Turkey Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. Saudi Arabia Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 105. Saudi Arabia Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. UAE Irbesartan Sales Growth Rate (2016-2021) (KG) Figure 107. UAE Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 108. Irbesartan Value Chain Figure 109. Channels of Distribution Figure 110. Distributors Profiles Figure 111. Bottom-up and Top-down Approaches for This Report Figure 112. Data Triangulation Figure 113. Key Executives Interviewed

Teva Sanofi BMS Sumitomo Dainippon Pharma Novartis Shionogi Hanall Taj Pharmaceuticals Apotex Jiangsu Hengrui Medicine Verdant Life Sciences Angita Pharma Auro Pharma Avanstra Zhuhai Rundu Pharma Xiansheng Pharmaceutical CTTQ Tianjin Huairen Pharmaceutical Jiangsu Wangao Pharmaceutical Zhejiang Huahai Pharmaceutical Zhejiang Ainuo Pharmaceutical Yuanhe Pharmaceutical